In 2020, DIANA Biotechnologies entered the PCR diagnostics market and developed and launched highly sensitive PCR tests for covid-19 from saliva in record time. This diagnostic is unique worldwide and has a patent application pending in the USA.
Panel for Diagnostics of Respiratory Viruses
PCR Life Science
PCR Mixes, Enzymes, RNase Inhibitors and Oligos
LOOKING FOR DISTRIBUTORS!
We are expanding our global network of business partners and looking for distributors for our PCR products. If you are interested, let us know!
Our 3 main business segments
- Development and production of innovative PCR diagnostics (incl. direct PCR technology)
- Leadership in PCR testing of COVID-19 and other respiratory viruses
- In-house bioinformatics, enzyme development, oligo synthesis
- Early drug discovery platform: assay development, HST screening, selectivity profiling, ADME testing
- CRO services for pharma industry
- In-house programs in virology and oncology
- Unique pipeline for development of high-affinity monoclonal antibodies
- Protein, peptide and small molecular targets, both diagnostic and therapeutic applications
The largest producer of COVID-19 PCR tests in Czechia
~40 % market share in COVID-19 PCR tests in Czechia
(public and private)